Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...

Novavax, Inc. (Nasdaq: NVAX) today announced that James Young, PhD, is retiring as Chair of the Board and Margaret McGlynn, ...

Effectiveness of 2024-25 COVID-19 vaccination against a COVID-19–associated ED/UC visit was 33% (95% confidence interval [CI] ...

Canada has torn up a deal with US biotech firm Novavax for Covid vaccines that were to be produced locally from a new Canadian fac ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Not all COVID-19 vaccines are mRNA vaccines. Novavax has a protein-based vaccine to protect against ... pushing restrictions ...

If passed, anyone who provides or administers a gene-based vaccine to another person would face a penalty of $500 per violation.

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...

Another recent federal study, published in the journal JAMA Pediatrics in February, showed approximately 1.01 million ...

has removed the clinical hold on Novavax's Investigational New Drug (IND) application for its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine candidates. The FDA has cleared ...

Ottawa: Canada has torn up a deal with US biotech firm Novavax for Covid vaccines that were to be produced locally from a new Canadian facility, according to regulatory filings Tuesday.